Blood Cancer Research
Deep molecular profiling of blood cancers
Archer® Blood Cancer research tests detect various driver mutations in hematologic malignancies, such as myeloid and lymphoid diseases, by targeted next-generation sequencing (NGS).
This approach combines FusionPlex® and VariantPlex® panels to characterize gene fusions, point mutations, copy number variations (CNVs) and other variant types from a single sample.
All Archer panels are powered by Anchored Multiplex PCR (AMP™) chemistry and follow the same workflow for maximum efficiency
Get the most information from your sample - fusions, CNVs, SNVs, indels and expression levels.
Coverage combined with powerful bioinformatics enable variant detection of traditionally difficult regions like CEBPA & FLT3
Powerful bioinformatics combined with orthogonal variant verification.